Kiora Pharmaceuticals, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes KIO-301, which is designed to restore vision in patients with inherited and age-related degenerative retinal disease, KIO-101 for patients with Ocular Presentation of Rheumatoid Arthritis, KIO-201 for patients undergoing PRK surgery for corneal wound repair after refractive surgery, and KIO-102. The company was founded in 1998 and is headquartered in Encinitas, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
13
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Kiora Pharmaceuticals Inc market cap is $3.19M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Kiora Pharmaceuticals Inc 52 week high is $2.91 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Kiora Pharmaceuticals Inc 52 week low is $0.7202 as of November 22, 2026.
Kiora Pharmaceuticals Inc stock price today is $0.7202.
Kiora Pharmaceuticals Inc stock price yesterday was $0.821.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Kiora Pharmaceuticals Inc's P/E ratio is -0.25.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Kiora Pharmaceuticals Inc P/B ratio is 0.2083.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Kiora Pharmaceuticals Inc 50-day moving average is $2.11.